The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Eli Lilly and Novo Nordisk have agreed pricing deals for GLP-1RA brands, a pivotal moment in the obesity treatment market.

The White House has secured another deal with major pharmaceutical companies, this time to offer popular weight loss drugs ...

The White House is expected to announce a deal for lower prices of obesity drugs from Novo Nordisk and Eli Lilly on Thursday ...

The White House announced reduced pricing for the popular weight-loss drugs made by Eli Lilly and Novo Nordisk.

The Trump administration initially walked back a Biden-era attempt to broaden Medicare coverage of weight loss drugs, which ...

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

The deal is expected to lower the price of some obesity drugs to $149 per month in certain cases, according to reports.